# FDA Inspection 1236571 - Intercept Pharmaceuticals, Inc. - April 22, 2024

Source: https://www.keypedia.com/records/fda_inspections/intercept-pharmaceuticals-inc/3a3ba5e7-11c8-4c49-8ecc-4b9fc08ccad1
Source feed: FDA_Inspections

> FDA Inspection 1236571 for Intercept Pharmaceuticals, Inc. on April 22, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1236571
- Company Name: Intercept Pharmaceuticals, Inc.
- Inspection Date: 2024-04-22
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1257609 - 2024-11-14](https://www.keypedia.com/records/fda_inspections/intercept-pharmaceuticals-inc/2ba14220-a453-442b-aed4-6dd6f45cc486)
- [FDA Inspection 1257609 - 2024-11-14](https://www.keypedia.com/records/fda_inspections/intercept-pharmaceuticals-inc/4934c8f7-5005-41df-949f-d3af69d90584)

Company: https://www.keypedia.com/companies/intercept-pharmaceuticals-inc/a2d7de0c-c1b2-4078-a084-cc07cd0b86a8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c